Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes

Running, not enrolling · Not applicable

Conditions studied: Type 1 Diabetes, Eating Disorders

In brief

This study aims to test the effectiveness of an evidence-based eating-disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating disorder prevention program to have repeatedly produced effects when evaluated by independent researchers, produced stronger effects than credible alternative interventions, and affected objective outcomes. DBP has been adapted slightly for individuals with T1D who are at ultra-high risk for eating disorders. The study aims to test the effectiveness of the DBP of reducing body image concerns and reducing eating pathology and improving glycemic control.

Key facts

Study ID

NCT05399446

Run by

Oslo University Hospital

People needed

280

Starts

2023-01-01

Expected to finish

2027-01-01

Last updated by the study team

2024-10-04

Who can join

Age: 14 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• between the ages of 14-35
• diagnosis of Type 1 Diabetes of at least 1 year
• using insulin
• experiencing at least some level of body image concerns

You may not qualify if…

• not between the ages of 14-35
• does not have access to wifi (will need for the virtual groups)
• Type 1 Diabetes diagnosis of less than 1 year
• does not live in the same time zone of Stanford (helps in coordinating groups)
• hospitalized for eating disorder treatment in the past year
• had eating-disorder related Diabetic Ketoacidosis (DKA) in the past year
• not using insulin
• not experiencing any level of body image concerns
• Unwilling to be video-recorded if assigned to Diabetes Body Project
• restricted proficiency in language that groups will be conducted in (dependent on location), and pervasive developmental, cognitive, or psychiatric limitations that compromise participation in the intervention sessions and study.

Where it is running

• Stanford University — Stanford, California, United States
• Joslin Diabetes Center — Boston, Massachusetts, United States
• Amsterdam Medical University Center — Amsterdam, Netherlands
• Oslo University Hospital — Oslo, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.